Press Releases Crescita Therapeutics Inc.

Equities

CTX

CA2258471028

Market Closed - Toronto S.E. Other stock markets 03:01:04 2024-05-03 pm EDT			5-day change	1st Jan Change
0.43 ^CAD	0.00%		0.00%	-12.24%

Mar. 13	Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share	MT
Mar. 13	Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Crescita Reports Q4 and Fiscal 2023 Results	Mar. 13	BU
Crescita Reports Third Quarter 2023 Results	Nov. 08	BU
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid	23-08-29	BU
Crescita Reports Second Quarter 2023 Results	23-08-09	BU
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders	23-06-21	BU
Crescita Reports First Quarter 2023 Results	23-05-11	BU
Crescita Reports Q4 and Fiscal 2022 Results	23-03-15	BU
Crescita Reports Third Quarter 2022 Results	22-11-09	BU
Crescita Reports Second Quarter 2022 Results	22-08-10	BU
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders	22-05-12	BU
Crescita Reports First Quarter 2022 Results	22-05-11	BU
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference	22-04-21	BU
Crescita Reports Q4 and Fiscal 2021 Results	22-03-23	BU
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid	21-12-15	BU
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis	21-12-14	AQ
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®	21-12-13	BU
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member	21-11-11	BU
Crescita Therapeutics : Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC	21-09-09	BU
Crescita Therapeutics : Acquires Minority Interest in The Best You®	21-09-07	BU
Crescita Therapeutics : and STADA Enter 15-Country Exclusive Licensing Agreement for Pliaglis®	21-08-18	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Crescita Therapeutics Inc.

Equities

CTX

CA2258471028

Press Releases

Filters